Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 134,565 | 7,416 | 13,187 | 54,636 | 18,957 |
| Receivables | 611 | 136 | 1,919 | 4,799 | 4,385 |
| Inventories | N/A | N/A | 20 | 38 | 3 |
| TOTAL | $138,890 | $8,395 | $16,416 | $61,845 | $26,005 |
| Non-Current Assets | |||||
| PPE Net | 1,209 | 1,965 | 2,411 | 2,695 | 1,607 |
| Intangibles | 10,502 | 10,502 | 14,409 | 14,447 | 15,994 |
| Other Non-Current Assets | 131 | 131 | 131 | 1,227 | 149 |
| TOTAL | $11,842 | $12,598 | $16,951 | $18,369 | $17,750 |
| Total Assets | $150,732 | $20,993 | $33,367 | $80,214 | $43,755 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 283 | 446 | 2,882 | 3,369 | 2,574 |
| Accrued Expenses | 6,317 | 4,172 | 13,214 | 16,519 | 11,310 |
| Other current liabilities | 360 | N/A | N/A | N/A | N/A |
| TOTAL | $6,960 | $4,618 | $22,114 | $19,888 | $15,225 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 13,486 | 32,833 | N/A |
| Deferred Revenues | N/A | N/A | 88 | N/A | N/A |
| Other Non-Current Liabilities | 10,470 | 8,916 | 8,541 | 4,298 | 3,878 |
| TOTAL | $10,740 | $9,071 | $22,168 | $37,244 | $3,968 |
| Total Liabilities | $17,700 | $13,689 | $44,282 | $57,132 | $19,193 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,672 | 1,034 | 55 | 39 | 31 |
| Common Shares | 10 | 1 | 0 | 9 | 75 |
| Retained earnings | -370,263 | -335,134 | -303,824 | -262,166 | -177,790 |
| TOTAL | $133,032 | $7,304 | $-10,915 | $23,082 | $24,562 |
| Total Liabilities And Equity | $150,732 | $20,993 | $33,367 | $80,214 | $43,755 |